Enrolling by Invitation
A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.
NCT07180511
- Conditions
- Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- EnitiateBioPharma Hangzhou, Zhejiang, China